NCT04008186View on ClinicalTrials.gov

A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

PHASE1CompletedINTERVENTIONAL

Enrollment

61

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

August 18, 2019

Study Completion Date

August 28, 2019

Conditions

Healthy Adult Subjects

Interventions

DRUG

Omaveloxolone

50 mg capsules

DRUG

Midazolam oral solution

2 mg/mL oral solution

DRUG

Repaglinide 1 MG

1 mg tablet

DRUG

MetFORMIN 500 Mg Oral Tablet

500 mg tablet

DRUG

Rosuvastatin

10 mg tablet

DRUG

Digoxin tablet

0.25 mg tablet

DRUG

Gemfibrozil Tablets

600 mg tablet

DRUG

Itraconazole capsule

100 mg capsule

DRUG

Verapamil Pill

120 mg tablet

Trial Locations (1)

75247

Covance Clinical Research Unit (CRU) Inc., Dallas

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Covance

INDUSTRY

lead

Biogen

INDUSTRY